McCrone, P., Payan, C. A., Knapp, M., Ludolph, A., Agid, Y., Leigh, P. N., Bensimon, G. :
The Economic Costs of Progressive Supranuclear Palsy and Multiple System Atrophy in France, Germany and the United Kingdom
PLoS ONE, 2011 ; 6 (9) : e24369
Publications (1184)
Vilquin, J. T., Catelain, C., Vauchez, K. :
Cell therapy for muscular dystrophies: advances and challenges Curr Opin Organ Transplant, 2011 ; 16 (6) : 640-649
Cell therapy for muscular dystrophies: advances and challenges Curr Opin Organ Transplant, 2011 ; 16 (6) : 640-649
Bevilacqua, J. A., Monnier, N., Bitoun, M., Eymard, B., Ferreiro, A., Monges, S., Lubieniecki, F., Taratuto, A. L., Laquerriere, A., Claeys, K. G., Marty, I., Fardeau, M., Guicheney, P., Lunardi, J., Romero, N. B. :
Recessive RYR1 mutations cause unusual congenital myopathy with prominent nuclear internalisation and large areas of myofibrillar disorganisation Neuropathol Appl Neurobiol, 2011 ; 37 (3) : 271-284
Recessive RYR1 mutations cause unusual congenital myopathy with prominent nuclear internalisation and large areas of myofibrillar disorganisation Neuropathol Appl Neurobiol, 2011 ; 37 (3) : 271-284
Ho, A. T., Hayashi, S., Brohl, D., Aurade, F., Rattenbach, R., Relaix, F. :
Neural Crest Cell Lineage Restricts Skeletal Muscle Progenitor Cell Differentiation through Neuregulin1-ErbB3 Signaling Dev Cell, 2011 ; 21 (2) : 273-287
Neural Crest Cell Lineage Restricts Skeletal Muscle Progenitor Cell Differentiation through Neuregulin1-ErbB3 Signaling Dev Cell, 2011 ; 21 (2) : 273-287
Ono, Y., Calbaheu, F., Morgan, J. E., Katagiri, T., Amthor, H., Zammit, P. S. :
BMP signalling permits population expansion by preventing premature myogenic differentiation in muscle satellite cells Cell Death Differ, 2011 ; 18 (2) : 222-234
BMP signalling permits population expansion by preventing premature myogenic differentiation in muscle satellite cells Cell Death Differ, 2011 ; 18 (2) : 222-234
Arzel-Hezode, M., Sternberg, D., Tabti, N., Vicart, S., Goizet, C., Eymard, B., Fontaine, B., Fournier, E. :
Homozygosity for dominant mutations increases severity of muscle channelopathies Muscle Nerve, 2010 ; 41 (4) : 470-7
Homozygosity for dominant mutations increases severity of muscle channelopathies Muscle Nerve, 2010 ; 41 (4) : 470-7
Finsterer, J., Ramaciotti, C., Wang, C. H., Wahbi, K., Rosenthal, D., Duboc, D., Melacini, P. :
Cardiac Findings in Congenital Muscular Dystrophies Pediatrics, 2010 ; 126 (3) : 538-545
Cardiac Findings in Congenital Muscular Dystrophies Pediatrics, 2010 ; 126 (3) : 538-545
Mitchell, K. J., Pannerec, A., Cadot, B., Parlakian, A., Besson, V., Gomes, E. R., Marazzi, G., Sassoon, D. A. :
Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development Nat Cell Biol, 2010 ; 12 (3) : 257-66
Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development Nat Cell Biol, 2010 ; 12 (3) : 257-66
Wang, C. H., Bonnemann, C. G., Rutkowski, A., Sejersen, T., Bellini, J., Battista, V., Florence, J. M., Schara, U., Schuler, P. M., Wahbi, K., Aloysius, A., Bash, R. O., Beroud, C., Bertini, E., Bushby, K., Cohn, R. D., Connolly, A. M., Deconinck, N., Desguerre, I., Eagle, M., Estournet-Mathiaud, B., Ferreiro, A., Fujak, A., Goemans, N., Iannaccone, S. T., Jouinot, P., Main, M., Melacini, P., Mueller-Felber, W., Muntoni, F., Nelson, L. L., Rahbek, J., Quijano-Roy, S., Sewry, C., Storhaug, K., Simonds, A., Tseng, B., Vajsar, J., Vianello, A., Zeller, R. :
Consensus Statement on Standard of Care for Congenital Muscular Dystrophies J Child Neurol, 2010 ; 25 (12) : 1559-1581
Consensus Statement on Standard of Care for Congenital Muscular Dystrophies J Child Neurol, 2010 ; 25 (12) : 1559-1581
Boutin, S., Monteilhet, V., Veron, P., Leborgne, C., Benveniste, O., Montus, M. F., Masurier, C. :
Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors Hum Gene Ther, 2010 ; 21 (6) : 704-712
Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors Hum Gene Ther, 2010 ; 21 (6) : 704-712
